10.01.26 -- Oral Combination Therapies: Navigating Development Complexities

API batch homogeneity supports efficient manufacturing. Controlled delumping improves powder flow and chargeability while maintaining particle size integrity and reducing GMP-scale risks.

Biotechnology moves quickly, and successful innovation depends on more than breakthrough science. Learn how adaptable strategies can help teams connect emerging tools and manage uncertainty.

Connect shopfloor equipment with enterprise systems to streamline your data flow. See how automation standards enhance integration and see a live demonstration of unified line performance in action.

Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.

Chromatography resin is expensive, making proper maintenance vital. A comprehensive cleaning, regeneration, and storage program protects resin longevity, reduces risks, and more.

Paper-based processes slow down life sciences manufacturing and introduce compliance risks. Discover how digital procedures and electronic logbooks can boost accuracy, speed, and traceability.

Disconnected manufacturing data limits quality and AI readiness. A connected IT/OT foundation helps teams reduce downtime, improve QC speed, and turn production data into trusted intelligence.

In biopharmaceutical manufacturing, seemingly minor components like seals can pose significant risks to product purity. Overlooking them can lead to contamination and costly delays.

Strategic location, strong regulatory oversight, institutional stability, and deep expertise reduce risk, speed approvals, and enable reliable, long-term pharmaceutical development partnerships.

Antibody-oligonucleotide conjugates introduce conjugation and purification challenges that standard ADC process development wasn't designed to solve. Examine the practical approaches for each.

Pharma manufacturing strategy now extends beyond cost and capacity, with resilience, flexibility, alignment, and market proximity supporting lasting success.

Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

Biopharma’s push for faster delivery is shifting from automation to autonomous manufacturing. Explore how deeper connectivity and self‑optimizing systems are shaping the next frontier.

Achieve seamless scale-up and process versatility by utilizing multi-shaft mixing technology. Balance high-shear dispersion with vacuum integration to optimize complex formulations.